UNSPSC 51271635: Ropivacaine hydrochloride

This classification denotes a local anesthetic and amide with the molecular formula C17H26N2O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V910P86109, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-propyl-, monohydrochloride, (s)- but more generally known as ropivacaine hydrochloride, which bears US NIH Compound Identifier 175804. European Medicines Agency schedules Ropivacaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04264MIG.

UNSPSC 51271635 Ropivacaine hydrochloride is a Commodity code covering procurement of this local anesthetic pharmaceutical. State and local governments purchase ropivacaine hydrochloride primarily through health departments, hospital systems, correctional facilities, and emergency medical services for surgical anesthesia, pain management, and regional nerve block procedures. The drug is available in multiple concentrations and formulations (solution, single-dose vials, multi-dose vials) and is typically procured through competitive bidding against branded and generic suppliers. Issuing bodies include state health and human services departments, county hospital networks, municipal healthcare systems, and special-purpose health districts.

The source does not identify recent state and local contract opportunities under this code. Without posted RFP, RFQ, IFB, or ITB activity in the available record, geographic concentration and representative solicitation detail cannot be established.